Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised iSIZE on the transaction. Sony Interactive Entertainment (SIE) announced that it had entered into an agreement to acquire iSIZE Limited, a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BibliU on the transaction. BibliU announced the acquisition of Texas Book Company, a privately held company in Texas. This acquisition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Celest Therapeutics in the transaction. Celest Therapeutics (Shanghai) Co. Ltd (“Celest”) announced a collaboration with Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
You must be a Standard 1 Year member to access this content.
Lefosse, Wilson Sonsini Goodrich & Rosati and Pérez-Llorca acted as counsel to Conexa on the deal. Conexa has entered into a strategic merger with Zenklub to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Infinitum on the transaction. Infinitum announced announced $185 million in Series E funding led by Just Climate with participation from Galvanize...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on IP matters related to the transaction. Verve Therapeutics, Inc. (Nasdaq:VERV) announced the expansion of its relationship with Eli Lilly...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aqtual on the transaction. Aqtual announced it has completed a $16 million Series A round of financing co-led by Genoa Ventures,...
You must be a Standard 1 Year member to access this content.
Morgan, Lewis & Bockius is advising Cloud Light Technology Limited on the transaction, and Wilson Sonsini Goodrich & Rosati is advising Lumentum Holdings Inc. Hong Kong–based...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Evergrow in the transaction. Evergrow announced it has closed its clean energy tax credit transfer on its platform, one of the...
You must be a Standard 1 Year member to access this content.
